Product Usage: This product is intended for research purposes only.
All product information available on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. This product should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Semax 30mg
Semax 30 mg should be reconstituted with bacteriostatic water (BAC).
During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly same as standards.
Semax (MEHFPGP) is a synthetic heptapeptide analogue of the ACTH(4-10) fragment developed to retain specific peptide-signaling properties while exhibiting a distinct pharmacological profile. Experimental investigations have examined its interactions with melanocortin-associated signaling pathways, peptide-mediated regulatory networks, transcriptional control mechanisms, and signal transduction processes. Studies have also explored its influence on molecular signaling systems, receptor-associated regulatory pathways, and peptide-dependent cellular communication mechanisms. Research applications include neuropeptide pharmacology, melanocortin pathway investigation, peptide-signaling research, transcriptional regulation studies, receptor-ligand interaction analysis, and mechanistic evaluation of peptide-mediated signaling systems.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
3D Molecular Structure
Drag to rotate · scroll to zoom| Chemical Formula | C37H51N9O10S |
|---|---|
| Synonyms | MEHFPGP, (Pro8,Gly9,Pro10)ACTH-(4-10), H-Met-Glu-His-Phe-Pro-Gly-Pro-OH |
| Molar Mass | 813.93 g/mol |
| CAS Number | 80714-61-0 |
| PubChem CID | 9811102 |
| Total Compound Content | 30 mg per vial |
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
What is the relationship between Semax and ACTH in terms of receptor pharmacology?
Semax is derived from the ACTH(4-10) sequence, a fragment of the larger proopiomelanocortin (POMC)-derived peptide family. The ACTH(4-10) region retains interactions with melanocortin-associated signaling systems while exhibiting a pharmacological profile distinct from full-length ACTH. Experimental investigations have examined Semax in relation to melanocortin receptor-associated pathways, peptide-mediated regulatory mechanisms, transcriptional control processes, and downstream signaling networks. These characteristics make Semax a useful research tool for studies of melanocortin pharmacology and peptide-signaling mechanisms.
How does Semax interact with molecular signaling pathways in experimental systems?
Experimental investigations have examined Semax in relation to ERK/MAPK-associated signaling networks, transcriptional regulation processes, and peptide-mediated regulatory pathways. While the precise molecular mechanisms remain incompletely characterized, studies have explored interactions with receptor-associated signaling systems, intracellular communication pathways, and downstream regulatory networks involved in peptide pharmacology. These characteristics have established Semax as a valuable research tool for investigations of signal transduction mechanisms and peptide-mediated molecular regulation.
Why is the Pro-Gly-Pro C-terminal motif of Semax pharmacologically significant?
Semax contains a C-terminal Pro-Gly-Pro extension that influences peptide stability characteristics and enzymatic degradation susceptibility relative to shorter ACTH-derived fragments. This structural modification alters physicochemical properties and contributes to its distinct pharmacological profile. The Pro-Gly-Pro motif is frequently examined in studies of peptide structure-function relationships, enzymatic processing mechanisms, molecular stability, and the impact of sequence modifications on peptide-associated signaling systems.
-
-
SALE
-
SALE
-
-
-
SALE
-
SALE
